{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:27:50Z","timestamp":1761488870272},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T00:00:00Z","timestamp":1331078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00404-012-2257-y","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T11:13:06Z","timestamp":1331032386000},"page":"89-92","source":"Crossref","is-referenced-by-count":7,"title":["Pre-eclampsia following chemotherapy for breast cancer during pregnancy: case report and review of the literature"],"prefix":"10.1007","volume":"286","author":[{"given":"L.","family":"Massey Skatulla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Loibl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Schauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,7]]},"reference":[{"key":"2257_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/JCO.2008.17.4110","volume":"27","author":"H Stensheim","year":"2009","unstructured":"Stensheim H, M\u00f8ller B, van Dijk T, Foss\u00e5 SD (2009) Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 27:45\u201351","journal-title":"J Clin Oncol"},{"key":"2257_CR2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/GRF.0b013e318236e781","volume":"54","author":"JR Walton","year":"2011","unstructured":"Walton JR, Prasad MR (2011) Obstetric and neonatal outcomes of cancer treated during pregnancy. Clin Obstet Gynecol 54:567\u2013573","journal-title":"Clin Obstet Gynecol"},{"key":"2257_CR3","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1001\/archinte.1988.00380090118027","volume":"148","author":"D Doll","year":"1988","unstructured":"Doll D, Ringenberg Q, Yarbro J (1988) Management of cancer in pregnancy. Arch Intern Med 148:2058\u20132064","journal-title":"Arch Intern Med"},{"key":"2257_CR4","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/GRF.0b013e318236e9f9","volume":"54","author":"M Brewer","year":"2011","unstructured":"Brewer M, Kueck A, Runowicz CD (2011) Chemotherapy in pregnancy. Clin Obstet Gynecol 54:602\u2013618","journal-title":"Clin Obstet Gynecol"},{"key":"2257_CR5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archinte.1992.00400150093017","volume":"152","author":"D Zemlickis","year":"1992","unstructured":"Zemlickis D, Lishhner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G (1992) Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 152:573\u2013657","journal-title":"Arch Intern Med"},{"key":"2257_CR6","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1200\/JCO.2005.03.038","volume":"23","author":"AE Ring","year":"2005","unstructured":"Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA (2005) Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol 23:4192\u20134197","journal-title":"J Clin Oncol"},{"key":"2257_CR7","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1200\/JCO.1987.5.7.1098","volume":"5","author":"EE Reynoso","year":"1987","unstructured":"Reynoso EE, Shepherd FA, Messner HA, Farquharson HA, Garvey MB, Baker MA (1987) Acute leukemia study group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol 5:1098\u20131106","journal-title":"J Clin Oncol"},{"key":"2257_CR8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/1097-0142(19910201)67:3<703::AID-CNCR2820670329>3.0.CO;2-6","volume":"67","author":"J Zuazu","year":"1991","unstructured":"Zuazu J, Julia A, Sierra J, Valentin MG, Coma A, Sanz MA, Batlle J, Flores A (1991) Pregnancy outcome in hematologic malignancies. Cancer 67:703\u2013709","journal-title":"Cancer"},{"key":"2257_CR9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0301-2115(96)02444-X","volume":"67","author":"T M\u00fcller","year":"1996","unstructured":"M\u00fcller T, Hofmann J, Steck T (1996) Eclampsia after polychemotherapy for nodal-positive breast cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol 67:197\u2013198","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2257_CR10","unstructured":"Mignini L (2007) Antiplatelet agents for preventing and treating pre-eclampsia, WHO RHL commentary Geneva"},{"key":"2257_CR11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0270-9295(04)00132-9","volume":"24","author":"J Villar","year":"2004","unstructured":"Villar J, Abalos E, Nardin JM, Merialdi M, Carroli G (2004) Strategies to prevent and treat preeclampsia: evidence from randomized controlled trials. Semin Nephrol 24:607\u2013615","journal-title":"Semin Nephrol"},{"key":"2257_CR12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physiol.00043.2008","volume":"24","author":"A Wang","year":"2009","unstructured":"Wang A, Rana S, Karumanchi SA (2009) Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda) 24:147\u2013158","journal-title":"Physiology (Bethesda)"},{"key":"2257_CR13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/humupd\/dml016","volume":"12","author":"E Jauniaux","year":"2006","unstructured":"Jauniaux E, Poston L, Burton GJ (2006) Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Update 12:747\u2013755","journal-title":"Hum Reprod Update"},{"key":"2257_CR14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0002-9440(10)63192-6","volume":"164","author":"TH Hung","year":"2004","unstructured":"Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ (2004) Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 164:1049\u20131061","journal-title":"Am J Pathol"},{"key":"2257_CR15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.placenta.2004.04.002","volume":"26","author":"J Vanderlie","year":"2005","unstructured":"Vanderlie J, Venardos K, Clifton VL, Gude NM, Clarke FM, Perkins AV (2005) Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta 26:53\u201358","journal-title":"Placenta"},{"key":"2257_CR16","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3945\/ajcn.110.001156","volume":"94","author":"L Poston","year":"2011","unstructured":"Poston L, Igosheva N, Mistry HD, Seed PT, Shennan AH, Rana S, Karumanchi SA, Chappell LC (2011) Role of oxidative stress and antioxidant supplementation in pregnancy disorders. Am J Clin Nutr 94:1980\u20131985","journal-title":"Am J Clin Nutr"},{"key":"2257_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mvr.2007.04.009","volume":"75","author":"WP Mutter","year":"2008","unstructured":"Mutter WP, Karumanchi SA (2008) Molecular mechanisms of preeclampsia. Microvasc Res 75:1\u20138","journal-title":"Microvasc Res"},{"key":"2257_CR18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.placenta.2009.02.009","volume":"30","author":"GJ Burton","year":"2009","unstructured":"Burton GJ, Woods AW, Jauniaux E, Kingdom JC (2009) Rheological and physiological consequenses of conversion of the maternal spiral arteries for uteroplazental blood flow during human pregnancy. Placenta 30:473\u2013482","journal-title":"Placenta"},{"key":"2257_CR19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0303-7207(01)00687-6","volume":"187","author":"D Goldman-Wohl","year":"2002","unstructured":"Goldman-Wohl D, Yagel S (2002) Regulation of trophoblast invasion: from normal implantation to pre-eclampsia. Mol Cell Endocrinol 187:233\u2013238","journal-title":"Mol Cell Endocrinol"},{"key":"2257_CR20","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI119388","volume":"99","author":"Y Zhou","year":"1997","unstructured":"Zhou Y, Damsky CH, Fisher SJ (1997) Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 99:2152\u20132164","journal-title":"J Clin Invest"},{"key":"2257_CR21","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.HYP.0000187899.34379.b0","volume":"46","author":"C Lam","year":"2005","unstructured":"Lam C, Lim KH, Karumanchi SA (2005) Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46:1077\u20131085","journal-title":"Hypertension"},{"key":"2257_CR22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1753944708097114","volume":"3","author":"A Hawfield","year":"2009","unstructured":"Hawfield A, Bl Freedman (2009) Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection. Ther Adv Cardiovasc Dis 3:65\u201373","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"2257_CR23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/plac.2002.0803","volume":"23","author":"F Lyall","year":"2002","unstructured":"Lyall F, Myatt L (2002) The role of the placenta in pre-eclampsia: a workshop report. Placenta 23:142\u2013145","journal-title":"Placenta"},{"key":"2257_CR24","doi-asserted-by":"crossref","first-page":"e16540","DOI":"10.1371\/journal.pone.0016540","volume":"26","author":"C Dechanet","year":"2011","unstructured":"Dechanet C, Fort A, Barbero-Camps E, Dechaud H, Richard S, Virsolvy A (2011) Endothelin-dependent vasoconstriction in human uterine artery: application to preeclampsia. PLoS ONE 26:e16540","journal-title":"PLoS ONE"},{"key":"2257_CR25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preghy.2010.10.007","volume":"1","author":"I Agarwal","year":"2011","unstructured":"Agarwal I, Karumanchi SA (2011) Preeclampsia and the anti-angiogenic state. Pregnancy Hypertens 1:17\u201321","journal-title":"Pregnancy Hypertens"},{"key":"2257_CR26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649\u2013658","journal-title":"J Clin Invest"},{"key":"2257_CR27","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","volume":"355","author":"RJ Levine","year":"2006","unstructured":"Levine RJ, Lam C, Qian C et al (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355:992\u20131005","journal-title":"N Engl J Med"},{"key":"2257_CR28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C et al (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672\u2013683","journal-title":"N Engl J Med"},{"issue":"396","key":"2257_CR29","first-page":"e1","volume":"196","author":"F Lu","year":"2007","unstructured":"Lu F, Longo M, Tamayo E, Maner W, Al-Hendy A, Anderson GD, Hankins GDV, Saade GR (2007) The effect of over-expression of sFlt-1 on blood pressure and the occurence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol 196(396):e1\u2013e7","journal-title":"Am J Obstet Gynecol"},{"key":"2257_CR30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/HYPERTENSIONAHA.107.092098","volume":"50","author":"Z Li","year":"2007","unstructured":"Li Z, Zhang Y, Ying Ma J, Kapoun AM, Shao Q, Kerr I, Lam A, O`Young G, Sannajust F, Stathis P, Schreiner G, Karumanchi SA, Protter AA, Pollitt NS (2007) Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension 50:686\u2013692","journal-title":"Hypertension"},{"key":"2257_CR31","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1210\/en.2004-0533","volume":"145","author":"T Nagamatsu","year":"2004","unstructured":"Nagamatsu T, Fujii T, Kusumi M, Zou L, Yamashita T, Osuga Y, Momoeda M, Kozuma S, Taketani Y (2004) Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 145:4838\u20134845","journal-title":"Endocrinology"},{"key":"2257_CR32","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/HYPERTENSIONAHA.107.108837","volume":"51","author":"BD LaMarca","year":"2008","unstructured":"LaMarca BD, Gilbert G, Granger JP (2008) Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension 51:982\u2013988","journal-title":"Hypertension"},{"key":"2257_CR33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.genm.2008.03.013","volume":"5","author":"BD LaMarca","year":"2008","unstructured":"LaMarca BD, Alexander BT, Gilbert JS, Ryan MJ, Sedeek M, Murphy SR, Granger JP (2008) Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin? Gend Med 5:133\u2013138","journal-title":"Gend Med"},{"key":"2257_CR34","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/0002-9378(91)90017-L","volume":"165","author":"Y Wang","year":"1991","unstructured":"Wang Y, Walsh SW, Guo J, Zhang J (1991) The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 165:1695\u20131700","journal-title":"Am J Obstet Gynecol"},{"key":"2257_CR35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1081\/PRG-45767","volume":"24","author":"B Schauf","year":"2005","unstructured":"Schauf B, Becker S, Abele H, Klever T, Wallwiener D, Aydeniz B (2005) Effect of magnesium on red blood cell deformability in pregnancy. Hypertens Pregnancy 24:17\u201327","journal-title":"Hypertens Pregnancy"},{"key":"2257_CR36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1081\/PRG-120005387","volume":"21","author":"B Schauf","year":"2002","unstructured":"Schauf B, Lang U, Stute P, Schneider ST, Dietz K, Aydeniz B, Wallwiener D (2002) Reduced red-blood-cell deformability, an indicator for high fetal or maternal risk, is found in Preeklampsia and IUGR. Hypertension in pregnancy 21:147\u2013160","journal-title":"Hypertension in pregnancy"},{"key":"2257_CR37","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ajog.2005.06.034","volume":"193","author":"DB Carr","year":"2005","unstructured":"Carr DB, Epplein M, Johnson CO, Easterling TR, Critchlow CW (2005) A sister\u2019s risk: family history as a predictor of preeclampsia. Am J Obstet Gynecol 193:965\u2013972","journal-title":"Am J Obstet Gynecol"},{"key":"2257_CR38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1515\/JPM.2008.004","volume":"36","author":"S Mutze","year":"2008","unstructured":"Mutze S, Rudnik-Schoneborn S, Zerres K, Rath W (2008) Genes and the preeclampsia syndrome. J Perinat Med 36:38\u201358","journal-title":"J Perinat Med"},{"key":"2257_CR39","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1471-0528.1992.tb14436.x","volume":"99","author":"JF Tuohy","year":"1992","unstructured":"Tuohy JF, James DK (1992) Pre-eclampsia and trisomy 13. Br J Obstet Gynaecol 99:891\u2013894","journal-title":"Br J Obstet Gynaecol"},{"key":"2257_CR40","first-page":"159","volume-title":"Oxidativer Stress und Pharmaka","author":"N Zarkovic","year":"2005","unstructured":"Zarkovic N (2005) Antioxidatien in der Pravention und Chemotherapie von Tumoren. In: Siems W, Kramer K, Grune T (eds) Oxidativer Stress und Pharmaka. Govi-Verlag, Eschborn, pp 159\u2013174"},{"key":"2257_CR41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0002-9378(11)90672-3","volume":"163","author":"LD Odom","year":"1990","unstructured":"Odom LD, Plouffe L Jr, Butler WJ (1990) 5-fluorouracil exposure during the period of conception: report on two cases. Am J Obstet Gynecol 163:76\u201377","journal-title":"Am J Obstet Gynecol"},{"key":"2257_CR42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0890-6238(90)90064-3","volume":"4","author":"JN Kopelman","year":"1990","unstructured":"Kopelman JN, Miyazawa K (1990) Inadvertent 5-fluorouracil treatment in early pregnancy: a report of three cases. Reprod Toxicol 4:233\u2013235","journal-title":"Reprod Toxicol"},{"key":"2257_CR43","first-page":"63","volume":"24","author":"B Gaillard","year":"1995","unstructured":"Gaillard B, Leng JJ, Grellet J, Ducint D, Saux MC (1995) Transplacental passage of epirubicin. J Gynecol Obstet Biol Reprod (Paris) 24:63\u201368","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"2257_CR44","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1096-9926(199711)56:5<305::AID-TERA3>3.0.CO;2-W","volume":"56","author":"AR Scialli","year":"1997","unstructured":"Scialli AR, Waterhouse TB, Desesso JM, Rahman A, Goeringer GC (1997) Protective effect of liposome encapsulation on paclitaxel developmental toxicity in the rat. Teratology 56:305\u2013310","journal-title":"Teratology"},{"key":"2257_CR45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3816\/CLM.2001.n.023","volume":"2","author":"A Avil\u00e9s","year":"2001","unstructured":"Avil\u00e9s A, Neri N (2001) Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2:173\u2013177","journal-title":"Clin Lymphoma"},{"key":"2257_CR46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1158\/1538-7445.AM10-91","volume":"70","author":"S Loibl","year":"2010","unstructured":"Loibl S, Amant F, Kaufmann M, Ring A, Han S, Giermek J, Fehm T, Bontenbal M, Heinrigs M, Lenhard M, Scherr I, Mehta K, von Minckwitz G (2010) 1313 patients with breast cancer during pregnancy: results from a prospective and retrospective registry (GBG-20\/BIG02-03). Cancer Res 70:91","journal-title":"Cancer Res"},{"key":"2257_CR47","first-page":"8","volume":"6","author":"S Loibl","year":"2010","unstructured":"Loibl S (2010) Mammakarzinom in der Schwangerschaft. Interdisziplin\u00e4res Vorgehen und Behandlungsoptionen. Gyn\u00e4kologie 6:8\u201312","journal-title":"Gyn\u00e4kologie"},{"key":"2257_CR48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000136002","volume":"3","author":"S Loibl","year":"2008","unstructured":"Loibl S (2008) New therapeutic options for breast cancer during pregnancy. Breast Care 3:171\u2013176","journal-title":"Breast Care"},{"key":"2257_CR49","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.ejca.2010.09.010","volume":"46","author":"F Amant","year":"2010","unstructured":"Amant F, Deckers S, Van Calsteren K, Loibl S, Halaska M, Brepoels L, Beijnen J, Cardoso F, Gentilini O, Lagae L, Mir O, Neven P, Ottevanger N, Pans S, Peccatori F, Rouzier R, Senn HJ, Struikmans H, Christiaens MR, Cameron D, Du Bois A (2010) Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer 46:3158\u20133168","journal-title":"Eur J Cancer"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-012-2257-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-012-2257-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-012-2257-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:56:30Z","timestamp":1559066190000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-012-2257-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["2257"],"URL":"https:\/\/doi.org\/10.1007\/s00404-012-2257-y","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,7]]}}}